Persist AI
Persist AI is a biotechnology company pioneering the use of AI-driven robotics to accelerate and transform pharmaceutical formulation development. Their mission is to deliver life-saving drugs faster, with fewer side effects, and improved patient outcomes by leveraging advanced automation, machine learning, and high-throughput experimentation. Persist AI's integrated platform addresses the bottlenecks of traditional drug formulation by combining custom robotics, computational chemistry, and proprietary AI models, enabling rapid, scalable, and cost-effective development of complex drug delivery systems such as long-acting injectables. With a global presence and a team of experts in drug delivery, automation, and machine learning, Persist AI is committed to making advanced drug delivery systems more accessible and efficient for the pharmaceutical industry worldwide. The company also demonstrates a strong commitment to data protection, privacy, and security, implementing robust technical and organizational measures in compliance with international standards.
Persist AI
890 Embarcadero Dr., West Sacramento, CA, 95605
What We Do
A cloud-based robotic laboratory enabling remote, high-throughput formulation discovery and development. Scientists can design and request experiments online, with robots executing and analyzing the results in real time.
A proprietary AI toolkit trained on thousands of data points from high-throughput experiments, used to analyze complex formulation data, predict optimal formulations, and generate protocols for robotic execution.
A web-based platform where scientists can design formulation experiments remotely. Persist AI's robotic lab executes these experiments, providing rapid, high-throughput formulation development and analytical testing. All data is accessible through the cloud portal.
End-to-end formulation development by Persist's scientists using AI-driven automation and robotics. Services include feasibility studies, optimization, animal studies, cGMP transfer, and regulatory documentation support.
Automated aseptic manufacturing line for producing clinical and production batches after formulation discovery, supporting scale-up and commercial manufacturing needs. Commercial cGMP manufacturing services are coming soon in 2025.
Automated and manual analytical services for formulation characterization, including solids, liquids, and semi-solids. Capabilities include HPLC, spectrophotometry, Raman, and more, with robotic sampling for consistency and cost savings.
Vaccines
Digital Health Technologies
Drugs
Key People
Head of Advanced Manufacturing
Vice President of Business Development, Europe and Asia Markets
News & Updates
Persist AI secured $12 million in Series A funding to expand their cloud lab platform and deploy a cGMP-compatible manufacturing line, validating their vision to transform drug formulation development.
Persist AI raised $4 million in seed financing, led by 2048 Ventures, to accelerate the development of their AI-driven drug formulation platform.
Persist AI participated in the prestigious Y Combinator accelerator, Winter 2023 batch, furthering their growth and industry connections.
An in-depth article on Persist AI's $12M Series A funding, their mission to transform drug formulation development, and the impact of their AI-driven platform on accelerating drug delivery to patients.
Coverage of Persist AI's $4M seed round, led by 2048 Ventures, highlighting their innovative approach to long-acting injectable formulations and the potential to halve development timelines for chronic disease treatments.
Announcement of a collaboration between Persist AI and Nivagen to co-develop a next-generation manufacturing process for long-acting injectable drugs, leveraging AI-based formulation technology and advanced manufacturing capabilities.
Persist AI announces the addition of Dr. Amjad Basha Mohammad as Head of Advanced Manufacturing and Dr. Ramesh Rachapudi as VP of Business Development, strengthening their computational modeling and global business development capabilities.
An educational article explaining the fundamentals of pharmaceutical formulations, their role in drug development, and the benefits of advanced drug delivery systems like long-acting injectables and microspheres.